TRIAMCINOLONE ACETONIDE ointment

Ülke: ABD

Dil: İngilizce

Kaynak: NLM (National Library of Medicine)

Aktif bileşen:

Triamcinolone Acetonide (UNII: F446C597KA) (Triamcinolone - UNII:1ZK20VI6TY)

Mevcut itibaren:

Rebel Distributors Corp

INN (International Adı):

Triamcinolone Acetonide

Kompozisyon:

Triamcinolone Acetonide 0.25 mg in 1 g

Uygulama yolu:

TOPICAL

Reçete türü:

PRESCRIPTION DRUG

Terapötik endikasyonlar:

Topical corticosteroids are indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses. Topical corticosteroids are contraindicated in those patients with a history of hypersensitivity to any of the components of the preparation.

Ürün özeti:

Triamcinolone Acetonide Ointment USP, 0.025% 80 gram tubes   NDC 21695-503-80   Triamcinolone Acetonide Ointment USP, 0.1% 15 gram tubes   NDC 21695-504-15 80 gram tubes   NDC 21695-504-80 Store at controlled room temperature 15°-30°C (59°-86°F). March 2008 E. FOUGERA & CO. A division of Nycomed US Inc. MELVILLE, NEW YORK 11747 Repackaged by: REBEL DISTRIBUTORS CORP Thousand Oaks, CA 91320

Yetkilendirme durumu:

Abbreviated New Drug Application

Ürün özellikleri

TRIAMCINOLONE ACETONIDE- TRIAMCINOLONE ACETONIDE OINTMENT
REBEL DISTRIBUTORS CORP
----------
TRIAMCINOLONE ACETONIDE OINTMENT USP, 0.025%, 0.1%
RX ONLY
DESCRIPTION
The topical corticosteroids constitute a class of primarily synthetic
steroids used as anti-inflammatory
and anti-pruritic agents. Triamcinolone Acetonide Ointment USP
contains Triamcinolone Acetonide
[Pregna-1,4-diene-3,20-dione,9-fluoro-11,21-dihydroxy-16,17-[(1-methylethylidene)bis-(oxy)]-,
(11β,16α)-], with the molecular formula C
H FO and molecular weight 434.50. CAS 76-25-5.
Triamcinolone Acetonide Ointment USP, 0.025% contains: 0.25 mg of
triamcinolone acetonide per gram
in a base containing white petrolatum and mineral oil.
Triamcinolone Acetonide Ointment USP, 0.1% contains: 1 mg
triamcinolone acetonide per gram in a
base containing white petrolatum and mineral oil.
CLINICAL PHARMACOLOGY
Topical corticosteroids share anti-inflammatory, anti-pruritic and
vasoconstrictive actions. The
mechanism of anti-inflammatory activity of the topical corticosteroids
is unclear. Various laboratory
methods, including vasoconstrictor assays, are used to compare and
predict potencies and/or clinical
efficacies of the topical corticosteroids. There is some evidence to
suggest that a recognizable
correlation exists between vasoconstrictor potency and therapeutic
efficacy in man.
PHARMACOKINETICS: The extent of percutaneous absorption of topical
corticosteroids is determined by
many factors including the vehicle, the integrity of the epidermal
barrier, and the use of occlusive
dressings. Topical corticosteroids can be absorbed from normal intact
skin. Inflammation and/or other
disease processes in the skin increase percutaneous absorption.
Occlusive dressings substantially
increase the percutaneous absorption of topical corticosteroids. Thus,
occlusive dressings may be a
valuable therapeutic adjunct for treatment of resistant dermatoses
(See DOSAGE AND
ADMINISTRATION). Once absorbed through the skin, topical
corticosteroids are handled through
pharmacokinetic pa